SCHEMBL19857767

SCHEMBL19857767

CC(=O)CC(=O)Nc1ccc(Cl)cc1C(=O)c1ccc(N(C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.53
ALDH1A1 P00352 7/20 0.50
KDM4E B2RXH2 4/20 0.50
MAPT P10636 4/20 0.49
POLB P06746 3/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
MAPK1 P28482 1/20 0.49
TP53 P04637 2/20 0.48
CYP1A2 P05177 2/20 0.48
LMNA P02545 2/20 0.48
THRB P10828 1/20 0.48
GAA P10253 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
GABRP O00591 1/20 0.47
GABRD O14764 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13263480 0.85 SMN1; SMN2 (0.71) SMN1; SMN2ALDH1A1KDM4EMAPTPOLB
SCHEMBL19857833 0.85 MAPT (0.53) SMN1; SMN2ALDH1A1KDM4EMAPTPOLB
SCHEMBL19863788 0.79 ALDH1A1 (0.46) SMN1; SMN2ALDH1A1MAPTPOLBMEN1
SCHEMBL7528165 0.77 KDM4E (0.71) SMN1; SMN2ALDH1A1KDM4EPOLBMEN1
SCHEMBL6353639 0.77 SERPINE1 (0.74) ALDH1A1KDM4EPOLBTDP1
SCHEMBL30044907 0.75 KMT2A (0.63) SMN1; SMN2ALDH1A1KDM4EPOLBMEN1
SCHEMBL6510154 0.75 KMT2A (0.63) SMN1; SMN2ALDH1A1KDM4EPOLBMEN1
SCHEMBL19857713 0.73 MAPT (0.53) SMN1; SMN2ALDH1A1MAPTPOLBMEN1
SCHEMBL11452911 0.73 MAPT (0.63) SMN1; SMN2ALDH1A1KDM4EMAPTPOLB
SCHEMBL14916767 0.72 SMN1; SMN2 (0.68) SMN1; SMN2ALDH1A1KDM4EMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10577349-B2 Quinolinones as inhibitors of translation initiation complex Sanford Burnham Prebys Medical Discovery Institute (US) 2020-03-03 US disclosed
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex Sanford Burnham Prebys Medical Discovery Institute 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex EIF4E, EIF4A1, EIF4A2 SMN1; SMN2 1909/4885ALDH1A1 4269/4885KDM4E 1264/4885
US-10577349-B2 Quinolinones as inhibitors of translation initiation complex EIF4E, EIF4A1, EIF4A2 SMN1; SMN2 1909/4885ALDH1A1 4269/4885KDM4E 1264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.